Olimel 5.7% E 0.81 g (Magnesium Chloride EMULSION) 0.81 G

OlimeI 5.7% E 0.81 G is a magnesium chloride emulsion used for intravenous administration. This product, manufactured by Baxter Corporation in Canada, is designed to support electrolyte balance and muscle function.

Strength

0.81 G

Pack Size

1000/1500/2000/2500ML

Manufacturer / TM Owner

BAXTER CORPORATION

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

OlimeI 5.7% E 0.81 G is primarily used to replenish magnesium levels in the body. Magnesium chloride emulsions are often utilized in clinical settings to address deficiencies that may arise from various conditions, including gastrointestinal disorders or prolonged intravenous therapy. This product is administered intravenously to ensure rapid absorption and effectiveness.

Side Effects

When administered as directed, OlimeI 5.7% E 0.81 G helps to maintain normal muscle and nerve function. It may also contribute to the regulation of heart rhythm and blood pressure. As with any intravenous medication, users may experience localized effects such as mild discomfort at the injection site.

Precautions & Warnings

OlimeI 5.7% E 0.81 G should be handled with care to ensure sterility and proper administration. It is essential to follow healthcare provider instructions regarding dosage and administration to avoid potential complications. Always check the packaging for any visible damage before use.

Avoid Interactions

Magnesium chloride emulsions like OlimeI 5.7% E 0.81 G may interact with certain medications, including diuretics and antibiotics. It is important to inform healthcare providers of all current medications to avoid potential interactions. Additionally, caution should be exercised when combining with other intravenous treatments.

Frequently Asked Questions

OlimeI 5.7% E 0.81 G is used to replenish magnesium levels in the body, supporting muscle and nerve function.

OlimeI 5.7% E 0.81 G is administered intravenously to ensure rapid absorption and effectiveness.

OlimeI 5.7% E 0.81 G helps maintain normal muscle and nerve function and may contribute to heart rhythm regulation.

Always follow healthcare provider instructions for dosage and administration to avoid complications.

Yes, it may interact with diuretics and antibiotics, so inform healthcare providers of all current medications.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.